WAY trades at a 36.6 P/E despite an RSI of 32.6, suggesting the market hasn't fully repriced recent weakness into valuation—a curious disconnect for a healthcare IT integrator in a consolidating space. With short interest at only 6.7% of float, there's minimal squeeze risk, but the modest short positioning combined with elevated multiples raises questions about whether the stock has genuinely de-risked or simply stalled at costly levels. The $4.1B market cap sits well below 52-week highs, indicating meaningful drawdown, yet the valuation premium persists relative to broader tech services peers, implying either hidden growth expectations or a valuation reset still in motion.
Snapshot
Recent headlines
Peers in Services-Computer Integrated Systems Design
Build a thesis around WAY
Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.
Open in AlgoThesis →